• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

住院COVID-19患者死亡率的三峰模式分析——来自三级医院的经验教训

Analysis of trimodal pattern of mortality among hospitalized COVID-19 patients- Lessons from tertiary care hospital.

作者信息

Paul Gunchan, Gautam Parshotam Lal, Sharma Shruti, Kumar Jeevan, Gupta Apoorva, Sharma Mukul, Khehra Akashdeep Singh, Paul Birinder S, Mohan Bishav

机构信息

Department of Critical Care Medicine, Dayanand Medical College and Hospital, Ludhiana, Punjab, India.

Department of Research & Development, Dayanand Medical College and Hospital, Ludhiana, Punjab, India.

出版信息

J Anaesthesiol Clin Pharmacol. 2022 Jul;38(Suppl 1):S107-S114. doi: 10.4103/joacp.joacp_58_22. Epub 2022 Jun 15.

DOI:10.4103/joacp.joacp_58_22
PMID:36060178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9438816/
Abstract

BACKGROUND AND AIMS

Many patients with COVID-19 become critically ill and requireICU admission. Risk factors associated with mortality have been studied, but this study provides insight regarding disease progression and hence help to plan rescue strategies to improve patient outcome.

MATERIAL AND METHODS

This retrospective, observational study included all patients with diagnosis of COVID-19 from March1 to June30,2021 who died in hospital.

RESULTS

During the study period, 1600 patients were admitted, with 1138 (71%) needing ICU care. There were 346 (21.6%) deaths, distributed as 15.8%(n = 55) within 48h of admission, 46.2%(n = 160) in next 10 days, and 37.8%(n = 131) thereafter. This trimodal mortality pattern of distribution was similar to polytrauma patients. Patients were divided into categories according to time duration from admission to death. In our cohort, 235 (14.7%) patients required mechanical ventilation, with a mortality of 85.4%(n = 201). Tachypnea was significantly (P < 0.001) associated with death at all times; however, hypotension was associated with early death and low oxygen saturation with poor outcome upto 10 days (P < 0.001). Refractory hypoxia was cause of death in all three groups, while other causes in group II were AKI (28%), sepsis (18%), and MODS (10%). Group III patients had different causes of mortality, including barotrauma (9%), pulmonary thromboembolism (8%), refractory hypercarbia (12%), MODS (13%), AKI (10%), sepsis (7%), and cardiac events (6%).

CONCLUSION

While physiological dearrangements are associated with rapid progression and early death, complications related to hyper-coagulable state, lung injury, and organ failure lead to death later. Providing quality care to a high volume of patients is a challenge for all, but posthoc analysis such as air crash investigation can help find out potential areas of improvement and contribute to better outcomes and mortality reduction.

摘要

背景与目的

许多新冠肺炎患者病情危重,需要入住重症监护病房(ICU)。与死亡率相关的危险因素已得到研究,但本研究深入探讨了疾病进展情况,从而有助于制定挽救策略以改善患者预后。

材料与方法

这项回顾性观察性研究纳入了2021年3月1日至6月30日期间在医院死亡的所有确诊新冠肺炎患者。

结果

在研究期间,共收治1600例患者,其中1138例(71%)需要重症监护。死亡346例(21.6%),分布情况如下:入院48小时内死亡15.8%(n = 55),接下来10天内死亡46.2%(n = 160),此后死亡37.8%(n = 131)。这种三峰分布的死亡模式与多发伤患者相似。根据从入院到死亡的时间长短将患者分类。在我们的队列中,235例(14.7%)患者需要机械通气,死亡率为85.4%(n = 201)。呼吸急促在各个时间段均与死亡显著相关(P < 0.001);然而,低血压与早期死亡相关,低氧饱和度与10天内的不良预后相关(P < 0.001)。难治性低氧是所有三组的死亡原因,而第二组的其他原因包括急性肾损伤(28%)、脓毒症(18%)和多器官功能障碍综合征(10%)。第三组患者有不同的死亡原因,包括气压伤(9%)、肺血栓栓塞(8%)、难治性高碳酸血症(12%)、多器官功能障碍综合征(13%)、急性肾损伤(10%)、脓毒症(7%)和心脏事件(6%)。

结论

虽然生理紊乱与疾病快速进展和早期死亡相关,但与高凝状态、肺损伤和器官衰竭相关的并发症会导致后期死亡。为大量患者提供优质护理对所有人来说都是一项挑战,但事后分析(如空难调查)有助于找出潜在的改进领域,并有助于改善预后和降低死亡率。

相似文献

1
Analysis of trimodal pattern of mortality among hospitalized COVID-19 patients- Lessons from tertiary care hospital.住院COVID-19患者死亡率的三峰模式分析——来自三级医院的经验教训
J Anaesthesiol Clin Pharmacol. 2022 Jul;38(Suppl 1):S107-S114. doi: 10.4103/joacp.joacp_58_22. Epub 2022 Jun 15.
2
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
3
Timing and causes of death in severe COVID-19 patients.严重 COVID-19 患者的死亡时间和原因。
Crit Care. 2021 Jun 30;25(1):224. doi: 10.1186/s13054-021-03639-w.
4
[Effect of early initiation of continuous renal replacement therapy based on the KDIGO classification on the prognosis of critically ill patients with acute kidney injury].基于KDIGO分类的早期启动连续性肾脏替代治疗对急性肾损伤危重症患者预后的影响
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2016 Mar;28(3):246-51.
5
Hydroxyethyl starch for fluid resuscitation in critically ill patients.羟乙基淀粉在危重症患者液体复苏中的应用。
Can J Anaesth. 2013 Jul;60(7):709-13. doi: 10.1007/s12630-013-9936-4. Epub 2013 Apr 20.
6
Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.双盲、随机、对照临床试验评估同种异体间充质基质细胞治疗 COVID-19 所致急性呼吸窘迫综合征患者的疗效(COVID-AT):一项随机对照试验的研究方案的结构总结。
Trials. 2021 Jan 6;22(1):9. doi: 10.1186/s13063-020-04964-1.
7
Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: A prospective, cohort, multicentre study.西班牙感染新型冠状病毒肺炎(SARS-CoV-2)的危重症患者的特征、临床病程及与重症监护病房(ICU)死亡率相关的因素:一项前瞻性队列多中心研究
Rev Esp Anestesiol Reanim (Engl Ed). 2020 Oct;67(8):425-437. doi: 10.1016/j.redar.2020.07.003. Epub 2020 Jul 13.
8
Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.阿根廷 COVID-19 有创通气患者的临床特征和结局(SATICOVID):一项前瞻性、多中心队列研究。
Lancet Respir Med. 2021 Sep;9(9):989-998. doi: 10.1016/S2213-2600(21)00229-0. Epub 2021 Jul 2.
9
Incidence and Outcomes of Acute Kidney Injury in Critically Ill Patients with Coronavirus Disease 2019.2019 年冠状病毒病危重症患者急性肾损伤的发生率和结局。
Saudi J Kidney Dis Transpl. 2021 Jan-Feb;32(1):84-91. doi: 10.4103/1319-2442.318551.
10
The Association of New-Onset Acute Kidney Injury and Mortality in Critically Ill Patients With COVID-19 With Less Severe Clinical Conditions at Admission: A Moderation Analysis.新冠肺炎危重症患者新发急性肾损伤与入院时临床病情较轻患者死亡率的关联:一项调节分析
Front Med (Lausanne). 2022 Mar 18;9:799298. doi: 10.3389/fmed.2022.799298. eCollection 2022.

引用本文的文献

1
Comorbid Asthma Increased the Risk for COVID-19 Mortality in Asia: A Meta-Analysis.合并哮喘增加亚洲地区2019冠状病毒病死亡风险:一项荟萃分析
Vaccines (Basel). 2022 Dec 30;11(1):89. doi: 10.3390/vaccines11010089.

本文引用的文献

1
Hematological profile and biochemical markers of COVID-19 non-survivors: A retrospective analysis.新型冠状病毒肺炎死亡患者的血液学特征和生化标志物:一项回顾性分析。
Clin Epidemiol Glob Health. 2021 Jul-Sep;11:100770. doi: 10.1016/j.cegh.2021.100770. Epub 2021 May 8.
2
ICU outcomes and survival in patients with severe COVID-19 in the largest health care system in central Florida.佛罗里达州中部最大医疗系统中重症 COVID-19 患者的 ICU 结局和生存率。
PLoS One. 2021 Mar 25;16(3):e0249038. doi: 10.1371/journal.pone.0249038. eCollection 2021.
3
On the analysis of mortality risk factors for hospitalized COVID-19 patients: A data-driven study using the major Brazilian database.
关于住院COVID-19患者死亡风险因素的分析:一项使用巴西主要数据库的数据驱动研究。
PLoS One. 2021 Mar 18;16(3):e0248580. doi: 10.1371/journal.pone.0248580. eCollection 2021.
4
Estimation of case-fatality rate in COVID-19 patients with hypertension and diabetes mellitus in the New York state: a preliminary report.纽约州 COVID-19 合并高血压和糖尿病患者病死率的评估:初步报告。
Epidemiol Infect. 2021 Jan 8;149:e14. doi: 10.1017/S0950268821000066.
5
Outcomes Evaluated in Controlled Clinical Trials on the Management of COVID-19: A Methodological Systematic Review.关于新型冠状病毒肺炎管理的对照临床试验中评估的结果:一项方法学系统评价
Life (Basel). 2020 Dec 15;10(12):350. doi: 10.3390/life10120350.
6
COVID-19 mortality effects of underlying health conditions in India: a modelling study.印度基础健康状况对 COVID-19 死亡率的影响:一项建模研究。
BMJ Open. 2020 Dec 16;10(12):e043165. doi: 10.1136/bmjopen-2020-043165.
7
Corticosteroids for COVID-19: the search for an optimum duration of therapy.用于治疗新型冠状病毒肺炎的皮质类固醇:寻找最佳治疗时长
Lancet Respir Med. 2021 Jan;9(1):e8. doi: 10.1016/S2213-2600(20)30530-0. Epub 2020 Nov 26.
8
Analysis of the Risk Factors for Mortality in Adult COVID-19 Patients in Wuhan: A Multicenter Study.武汉成年新冠肺炎患者死亡风险因素分析:一项多中心研究
Front Med (Lausanne). 2020 Aug 25;7:545. doi: 10.3389/fmed.2020.00545. eCollection 2020.
9
A physiological approach to understand the role of respiratory effort in the progression of lung injury in SARS-CoV-2 infection.从生理学角度理解呼吸努力在 SARS-CoV-2 感染导致肺损伤进展中的作用。
Crit Care. 2020 Aug 10;24(1):494. doi: 10.1186/s13054-020-03197-7.
10
The Effect of Age on Mortality in Patients With COVID-19: A Meta-Analysis With 611,583 Subjects.年龄对 COVID-19 患者死亡率的影响:一项纳入 611583 例患者的荟萃分析。
J Am Med Dir Assoc. 2020 Jul;21(7):915-918. doi: 10.1016/j.jamda.2020.05.045. Epub 2020 May 25.